Establishing a COVID-19 pandemic severity assessment surveillance system in Ireland
© 2021 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd..
We developed a COVID-19 pandemic severity assessment (PSA) monitoring system in Ireland, in order to inform and improve public health preparedness, response and recovery. The system based on the World Health Organization (WHO) Pandemic Influenza Severity Assessment (PISA) project included a panel of surveillance parameters for the following indicators: transmissibility, impact and disease severity. Age-specific thresholds were established for each parameter and data visualised using heat maps. The findings from the first pandemic wave in Ireland have shown that the WHO PISA system can be adapted for COVID-19, providing a standardised tool for early warning and monitoring pandemic severity.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Influenza and other respiratory viruses - 16(2022), 1 vom: 01. Jan., Seite 172-177 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Domegan, Lisa [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 04.01.2022 Date Revised 05.10.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/irv.12890 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM331502917 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM331502917 | ||
| 003 | DE-627 | ||
| 005 | 20231225213615.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/irv.12890 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1104.xml |
| 035 | |a (DE-627)NLM331502917 | ||
| 035 | |a (NLM)34609049 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Domegan, Lisa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Establishing a COVID-19 pandemic severity assessment surveillance system in Ireland |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.01.2022 | ||
| 500 | |a Date Revised 05.10.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd. | ||
| 520 | |a We developed a COVID-19 pandemic severity assessment (PSA) monitoring system in Ireland, in order to inform and improve public health preparedness, response and recovery. The system based on the World Health Organization (WHO) Pandemic Influenza Severity Assessment (PISA) project included a panel of surveillance parameters for the following indicators: transmissibility, impact and disease severity. Age-specific thresholds were established for each parameter and data visualised using heat maps. The findings from the first pandemic wave in Ireland have shown that the WHO PISA system can be adapted for COVID-19, providing a standardised tool for early warning and monitoring pandemic severity | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a pandemic | |
| 650 | 4 | |a pandemic severity assessment | |
| 650 | 4 | |a surveillance | |
| 700 | 1 | |a Garvey, Patricia |e verfasserin |4 aut | |
| 700 | 1 | |a McEnery, Maeve |e verfasserin |4 aut | |
| 700 | 1 | |a Fiegenbaum, Rachel |e verfasserin |4 aut | |
| 700 | 1 | |a Brabazon, Elaine |e verfasserin |4 aut | |
| 700 | 1 | |a Quintyne, Keith Ian |e verfasserin |4 aut | |
| 700 | 1 | |a O'Connor, Lois |e verfasserin |4 aut | |
| 700 | 1 | |a Cuddihy, John |e verfasserin |4 aut | |
| 700 | 1 | |a O'Donnell, Joan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Influenza and other respiratory viruses |d 2007 |g 16(2022), 1 vom: 01. Jan., Seite 172-177 |w (DE-627)NLM176605215 |x 1750-2659 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2022 |g number:1 |g day:01 |g month:01 |g pages:172-177 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/irv.12890 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2022 |e 1 |b 01 |c 01 |h 172-177 | ||